Science & Technology
A novel CAR-T cell therapy for the one-time treatment of chronic HIV infection in patients who are not ART suppressed
Department of Health and Human Services — National Institutes of Health
Opportunity #: 4R42AI167175-02
Award Ceiling
$2.0M
Award Floor
$2.0M
Close Date
Jan 31, 2026
Total Funding
$2.0M
Expected Awards
1
Posted Date
Feb 13, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-4R42AI167175-02
Description
STTR Phase Phase II award: "A novel CAR-T cell therapy for the one-time treatment of chronic HIV infection in patients who are not ART suppressed" awarded to MARPAM PHARMA LLC in LANDFALL VILLAGE, Minnesota. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $1,979,499. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.